KYC’s Statement on the Johnson & Johnson COVID-19 Vaccine
Date: April 13, 2021
KYC’s most recent vaccination clinic distributed Johnson and Johnson’s single-dose COVID-19 vaccine on April 8th. Although side effects are rare, in accordance with the Center for Disease Control and Prevention (CDC) and the Food and Drug Administration’s (FDA) recommendation, we are encouraging anyone who experiences any side effects or concerns, especially including severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination to contact their health care provider immediately and inform them you recently received the vaccine.
Updates will continue to become available and KYC will continue to follow the CDC’s guidelines for all practices related to COVID-19. For more information regarding this and other vaccines, please consult the CDC’s website at https://cdc.gov. To view the CDC and FDA’s joint statement on the Johnson & Johnson COVID-19 vaccine from April 13th 2021, please click here.
Previous Article Next Article
